![PBS News Hour - World artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts62/v4/bc/f2/ab/bcf2ab53-d080-c1cd-f94b-594eccf82080/mza_9077819092595671400.png/100x100bb.jpg)
Waiving the vaccine patent may come down to giving pharmaceutical companies incentives
PBS News Hour - World
English - May 06, 2021 22:35 - 12.5 MB - ★★★★ - 79 ratingsNews world news current events newshour television radio media Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Indian doctors in the US have deep ties to India. Here's how they're helping from afar
Next Episode: Robert Gates on US action in Iran, Afghanistan and China
President Joe Biden has given the initial nod for the U.S. to waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action. William Brangham discusses the matter with Rachel Silverman, a policy fellow at the Center for Global Development. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders